Skip to main content
Premium Trial:

Request an Annual Quote

GATC Purchases Second Illumina Analyzer

NEW YORK (GenomeWeb News) – GATC Biotech has added a second Ilumina analyzer to its lab, the Constance, Germany-based company said today.
The sequencing services company has purchased an updated version of the Genome Analyzer that enables paired-end reads. GATC said the new instrument would help support increased demand “for projects for which up to 50 bp read length is sufficient,” such as resequencing genomes, microRNA, ChIP sequencing and other jobs.
The company also recently bought a second Genome Sequencer FLX system from Roche’s 454 Life Sciences’ subsidiary.
Last summer, GATC bought an Applied Biosystems SOLiD DNA sequencing system through ABI’s early-access program.
“The demand for sequencing projects which require a hybrid strategy is increasing,” said Kerstin Stangier, global key account manager of GATC. Stangier explained that adding the Genome Analyzer to its other systems “allows us to overcome the drawbacks of each system, for example the known homopolymer problem of the [454] pyrosequencing technology.”
GATC also said that it has been expanding its informatics infrastructure and has been hiring new informaticians and programmers to handle increased amounts of data. 
Financial terms of the agreement were not released.


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.